Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection

Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis

(2015) Chih-Chien Chin et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

(2015) Calin Cainap et al.   JOURNAL OF CLINICAL ONCOLOGY

Pyruvate kinase: Function, regulation and role in cancer

(2015) William J. Israelsen et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice

(2015) Weiqi Dai et al.   Oncotarget

Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy

(2015) Xue-bing Li et al.   Thoracic Cancer

Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma

(2015) Zhiao Chen et al.   Oncotarget

Evidence for Heightened Hexokinase II Immunoexpression in Hepatocyte Dysplasia and Hepatocellular Carcinoma

(2014) Grace Guzman et al.   DIGESTIVE DISEASES AND SCIENCES

Emerging trends in hepatocellular carcinoma incidence and mortality

(2014) Basile Njei et al.   HEPATOLOGY

Propranolol Inhibits Glucose Metabolism and 18F-FDG Uptake of Breast Cancer Through Posttranscriptional Downregulation of Hexokinase-2

(2014) F. Kang et al.   JOURNAL OF NUCLEAR MEDICINE

An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma

(2014) Songlin Peng et al.   PLoS One

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

(2013) Krushna C. Patra et al.   CANCER CELL

The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection

(2012) Dongtai Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition

(2012) Su Jong Yu et al.   JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Expression and Functional Coupling of Liver ß2-Adrenoceptors in the Human Hepatocellular Carcinoma

(2012) Woubet T. Kassahun et al.   PHARMACOLOGY

Choline Kinase Alpha and Hexokinase-2 Protein Expression in Hepatocellular Carcinoma: Association with Survival

(2012) Sandi A. Kwee et al.   PLoS One

Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period

(2011) Zhuanbo Luo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

TNM seventh edition: What's new, what's changed

(2010) Leslie H Sobin et al.   CANCER

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE